| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1642571A2 Method for preparing submicron particle suspensions |
| 04/05/2006 | EP1641789A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 04/05/2006 | EP1641480A1 Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent |
| 04/05/2006 | EP1641474A1 Therapeutical composition containing dentritic cells and use thereof |
| 04/05/2006 | EP1641470A1 Vaginal compositions for treating pelvic tissue infections and traumas |
| 04/05/2006 | EP1641452A1 Heterocyclic compounds useful to treat hcv |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1401489B1 Capsular polysaccharide solubilisation |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1333848B1 Phyllanthus-derived compounds for the prevention and/or treatment of diseases associated with a retrovirus |
| 04/05/2006 | EP1320355B1 System for delivering a tobramycin formulation |
| 04/05/2006 | EP1294720B1 Non-nucleoside reverse transcriptase inhibitors |
| 04/05/2006 | EP1244668B1 Purine derivatives, process for their preparation and use thereof |
| 04/05/2006 | EP1210104B1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | EP1115417B1 Use of daptomycin |
| 04/05/2006 | EP1107783B1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 04/05/2006 | EP1051162B1 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate |
| 04/05/2006 | EP0946188B1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 04/05/2006 | EP0933993B1 Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 04/05/2006 | EP0741792B1 Herpesvirus pre-(viral dna replication) enveloped particles |
| 04/05/2006 | EP0649435B1 Membrane-associated immunogens of mycobacteria |
| 04/05/2006 | CN1756957A Method of detecting onset risk of encephalitis or encephalopathy |
| 04/05/2006 | CN1756768A Trimeric polypeptide construct to induce an enduring t cell response |
| 04/05/2006 | CN1756563A Use of myxoma virus for therapeutic treatment of cancer and chronic viral infection |
| 04/05/2006 | CN1756555A Medicament |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1754889A Pegylated interferon alpha-1b |
| 04/05/2006 | CN1754884A Crystal form ii of clarithromycin |
| 04/05/2006 | CN1754879A Imidazole derivative compound, its salts and use thereof |
| 04/05/2006 | CN1754871A Preparation method and use of alpine yarrow herb ketoacid |
| 04/05/2006 | CN1754559A Traditional Chinese medicine compositions for AIDS and its preparation method and uses |
| 04/05/2006 | CN1754557A Chinese caterpillar fungus formulation preparation method |
| 04/05/2006 | CN1754555A Preparation method of traditional Chinese medicine compositions formulation |
| 04/05/2006 | CN1754554A Traditional Chinese medicine compositions |
| 04/05/2006 | CN1754552A Use of alpine yarrow herb effective parts in preparing medicine for respiratory tract virus |
| 04/05/2006 | CN1754551A Use of alpine yarrow herb effective parts in preparing medicine for suppressing Heptitis B virus and protecting liver |
| 04/05/2006 | CN1249242C non-resistance choosing for DNA vaccine carrier and its construction method |
| 04/05/2006 | CN1249241C HIV-like particles and use thereof |
| 04/05/2006 | CN1249227C 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249084C Human SARS virus surface membrane protein antigen determinant polypeptide, polynucleotide sequence and its use |
| 04/05/2006 | CN1249083C Polypeptide drug for inhibiting SARS coronavirus from infecting host cell |
| 04/05/2006 | CN1249081C Glycopeptide derivatives and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249072C Preparation method of golden peach glycoside and its new use in medicine |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249062C Substituted imidazopyridines |
| 04/05/2006 | CN1249061C Sulfonamide and sulfamide substituted imidazoquinolines and its pharmaceutical composition and uses |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249057C Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 04/05/2006 | CN1249052C Pyrazole derivatives as HIV reverse transcriptase inhibitors |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1249019C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 04/05/2006 | CN1248740C AIDS virus vaccine with use of sendai virus vector |
| 04/05/2006 | CN1248737C Vaccine containing saponin and sterol |
| 04/05/2006 | CN1248734C Matrix protein compositions for wound healing |
| 04/05/2006 | CN1248729C Poultry liquid medicine and its preparation method |
| 04/05/2006 | CN1248718C Medicinal composition for treating mycoplasma pneumonia and preparation method and quality-control method |
| 04/05/2006 | CN1248717C Liver benefiting Huangxuan Yigan Powder and its preparing process |
| 04/05/2006 | CN1248714C Hepatitis-treating medicine composition |
| 04/05/2006 | CN1248713C Chinese medicine for preventing and treating hydrophobia and its decoction method |
| 04/05/2006 | CN1248696C Quality control method of isatis root preparation |
| 04/05/2006 | CN1248671C Use of 3-position cyclosporin derivatives for hair growth |
| 04/05/2006 | CA2479539A1 Recombinant adenylate cyclase / hiv-tat protein and therapeutic and diagnostic uses thereof |
| 04/04/2006 | US7022852 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 04/04/2006 | US7022832 Wherein secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid; anticarcenogenic agents, treatment of Ewing's sarcoma |
| 04/04/2006 | US7022734 Use of a transition metal complex, other than deferoxamine-manganese, hemin, diethyldithiocarbamic acid complexes or an iron hemoprotein, in the manufacture of a medicament for the therapy of septic shock |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022712 Acidification of drugs such as carbendazim, by mixing with buffers improving water solubility; anticarcinogenic agents |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022705 such as (5RS)-3-(3-Fluoro-4-thiomorpholin-4-yl phenyl)-5-(1,2,3-triazol-1-ylmethyl)-4,5-dihydroisoxazole; antibiotics |
| 04/04/2006 | US7022691 Penicillinate compounds; bactericides for use against antibiotic resistant bacteria |
| 04/04/2006 | US7022689 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022669 such as 1-[4-[[(1H-benzimidazol-2-yl)-methyl]-amino]-N2-[[4'-(pentyloxy) [1,1':4', 1'' terphenyl]-4-yl]-carbonyl]-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B trifluoroacetate |
| 04/04/2006 | US7022667 Mycobacterium; grampositive bacteria bactericides, antibiotics |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022495 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 04/04/2006 | US7022328 Therapeutic and diagnostic compositions |
| 04/04/2006 | US7022326 Carboxymethylated retroviral regulatory proteins and interferon-α |
| 04/04/2006 | US7022320 Eliciting an immune response by administering a vector construct which comprising a recombinant polynucleotide, able encoding a Mycobacterium tuberculosis antigen in human; administering antigen protein, or live attenuated vaccine; gold core carrier; dna vaccines |
| 04/04/2006 | US7022319 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 04/04/2006 | US7022312 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 03/30/2006 | WO2006034337A2 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus |
| 03/30/2006 | WO2006034134A2 Antibacterial peptide with activity against b. anthracis |
| 03/30/2006 | WO2006033878A1 Process for preparing macrocyclic hcv protease inhibitors |
| 03/30/2006 | WO2006033851A1 Ring-closing metathesis process in supercritical fluid |
| 03/30/2006 | WO2006033453A1 Activity enhancer for interferon agent |
| 03/30/2006 | WO2006033422A1 Quinolizinone compound and use thereof as hiv integrase inhibitor |
| 03/30/2006 | WO2006032533A1 Novel vaccine for veterinary and human medicine prophylaxis and therapy |
| 03/30/2006 | WO2006032525A2 Combinational therapy for treating cancer |